Contrast-enhanced MR imaging in neuroimaging

Bum soo Kim; Juan E. Gutierrez

doi:10.1016/j.mric.2012.07.003

Contrast-enhanced MR imaging in neuroimaging

Bum soo Kim, Juan E. Gutierrez

Department of Radiology

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

MR imaging without and with gadolinium-based contrast agents (GBCAs) is an important imaging tool for defining normal anatomy and characteristics of lesions. GBCAs have been used in contrast-enhanced MR imaging in defining and characterizing lesions of the central nervous system for more than 20 years. The combination of unenhanced and GBCA-enhanced MR imaging is the clinical gold standard for the noninvasive detection and delineation of most intracranial and spinal lesions. MR imaging has a high predictive value that rules out neoplasm and most inflammatory and demyelinating processes of the central nervous system.

Original language	English (US)
Pages (from-to)	649-685
Number of pages	37
Journal	Magnetic Resonance Imaging Clinics of North America
Volume	20
Issue number	4
DOIs	https://doi.org/10.1016/j.mric.2012.07.003
State	Published - Nov 2012

Keywords

Contrast-enhanced MR imaging (CE MR imaging)
Diffusion-weighted imaging (DWI)
Gadolinium-based contrast agents (GBCAs)
Lineal agent
MR spectroscopy (MRS)
Microcyclic agent
Perfusion MR imaging (pMR imaging)
Susceptibility-weighted imaging (SWI)

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.mric.2012.07.003

Cite this

@article{b301e873b0ce4376ad36ead8a5dbb859,

title = "Contrast-enhanced MR imaging in neuroimaging",

abstract = "MR imaging without and with gadolinium-based contrast agents (GBCAs) is an important imaging tool for defining normal anatomy and characteristics of lesions. GBCAs have been used in contrast-enhanced MR imaging in defining and characterizing lesions of the central nervous system for more than 20 years. The combination of unenhanced and GBCA-enhanced MR imaging is the clinical gold standard for the noninvasive detection and delineation of most intracranial and spinal lesions. MR imaging has a high predictive value that rules out neoplasm and most inflammatory and demyelinating processes of the central nervous system.",

keywords = "Contrast-enhanced MR imaging (CE MR imaging), Diffusion-weighted imaging (DWI), Gadolinium-based contrast agents (GBCAs), Lineal agent, MR spectroscopy (MRS), Microcyclic agent, Perfusion MR imaging (pMR imaging), Susceptibility-weighted imaging (SWI)",

author = "Kim, {Bum soo} and Gutierrez, {Juan E.}",

year = "2012",

month = nov,

doi = "10.1016/j.mric.2012.07.003",

language = "English (US)",

volume = "20",

pages = "649--685",

journal = "Magnetic Resonance Imaging Clinics of North America",

issn = "1064-9689",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Contrast-enhanced MR imaging in neuroimaging

AU - Kim, Bum soo

AU - Gutierrez, Juan E.

PY - 2012/11

Y1 - 2012/11

N2 - MR imaging without and with gadolinium-based contrast agents (GBCAs) is an important imaging tool for defining normal anatomy and characteristics of lesions. GBCAs have been used in contrast-enhanced MR imaging in defining and characterizing lesions of the central nervous system for more than 20 years. The combination of unenhanced and GBCA-enhanced MR imaging is the clinical gold standard for the noninvasive detection and delineation of most intracranial and spinal lesions. MR imaging has a high predictive value that rules out neoplasm and most inflammatory and demyelinating processes of the central nervous system.

AB - MR imaging without and with gadolinium-based contrast agents (GBCAs) is an important imaging tool for defining normal anatomy and characteristics of lesions. GBCAs have been used in contrast-enhanced MR imaging in defining and characterizing lesions of the central nervous system for more than 20 years. The combination of unenhanced and GBCA-enhanced MR imaging is the clinical gold standard for the noninvasive detection and delineation of most intracranial and spinal lesions. MR imaging has a high predictive value that rules out neoplasm and most inflammatory and demyelinating processes of the central nervous system.

KW - Contrast-enhanced MR imaging (CE MR imaging)

KW - Diffusion-weighted imaging (DWI)

KW - Gadolinium-based contrast agents (GBCAs)

KW - Lineal agent

KW - MR spectroscopy (MRS)

KW - Microcyclic agent

KW - Perfusion MR imaging (pMR imaging)

KW - Susceptibility-weighted imaging (SWI)

UR - http://www.scopus.com/inward/record.url?scp=84867846625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867846625&partnerID=8YFLogxK

U2 - 10.1016/j.mric.2012.07.003

DO - 10.1016/j.mric.2012.07.003

M3 - Review article

C2 - 23088944

AN - SCOPUS:84867846625

SN - 1064-9689

VL - 20

SP - 649

EP - 685

JO - Magnetic Resonance Imaging Clinics of North America

JF - Magnetic Resonance Imaging Clinics of North America

IS - 4

ER -

Contrast-enhanced MR imaging in neuroimaging

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this